Thyrotoxic myopathy mimicking myasthenic syndrome associated with thymic hyperplasia

Internal Medicine

Volumn 47, Issue 5, 2008, Pages 445-447

  Tsuda, Emiko ^a   Imai, Tomihiro ^a   Matsumura, Akihiro ^a   Hisahara, Shin ^a   Nonaka, Michio ^a   Shiraishi, Hirokazu ^b   Motomura, Masakatsu ^b   Shimohama, Shun ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Grave's disease; Hyperthyroidism; Lambert Eaton myasthenic syndrome; Myasthenia gravis; Thymic hyperplasia; Thyrotoxic myopathy

Indexed keywords

EDROPHONIUM CHLORIDE; IODINE 123; LIOTHYRONINE; THIAMAZOLE; THYROTROPIN; THYROXINE; ANTITHYROID AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; ECHOGRAPHY; ELECTROMYOGRAPHY; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; LEG MUSCLE; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYASTHENIA LIKE SYNDROME; MYOPATHY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROLOGIC EXAMINATION; NEUROMUSCULAR JUNCTION DISORDER; SYMPTOM; THYMUS HYPERPLASIA; THYROID FUNCTION TEST; THYROID SCINTISCANNING; PATHOPHYSIOLOGY; THYROTOXICOSIS;

ADULT; ANTITHYROID AGENTS; DIAGNOSIS, DIFFERENTIAL; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; THYMUS HYPERPLASIA; THYROTOXICOSIS;

EID: 40949147016     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0682     Document Type: Article

References (14)

1. Ubogu EE, Ruff RL, Kaminski HJ. Endocrine myopathies. In: Myology. 3rd ed. Engel AG, Franzini-Armstrong C, Eds. McGraw-Hill, New York, 2004: 1713-1738.
2. Satoyoshi E, Murakami K, Kowa H, Kinoshita M. Myopathy in thyrotoxicosis: with special emphasis on an effect of potassium ingestion on serum and urinary creatine. Neurology 13: 645-658, 1963.
3. Ramsay I. Muscle dysfunction in hyperthyroidism. Lancet 931-934, 1966.
4. Puvanendran K, Cheah JS, Naganathan N, Wong PK. Thyrotoxic myopathy:A clinical and quantitative analytic electromyographic study. J Neurol Sci 42: 441-451, 1979.
5. Penn AS, Rowland LP. Myasthenia gravis. In: Merritt's Neurology. 10th ed. Rowland LP, Ed. Lippincott Williams & Wilkins, Philadelphia, 2000: 721-727.
6. Engstrom JW. Myasthenia gravis:diagnostic mimics. Semin Neurol 24: 141-147, 2004.
7. Mori M, Takamori M. Hyperthyroidism and myasthenia gravis with features of Eaton-Lambert syndrome. Neurology 26: 882-887, 1976.
8. Wirtz PW, Bradshaw J, Wintzen AR, Verschuuren JJ. Associated autoimmune diseases in patients with Lambert-Eaton myasthenic syndrome and their families. J Neurol 251: 1255-1259, 2004.
9. Meriggioli MN, Sanders DB. Myasthenia gravis:diaposis. Semin Neurol 24: 31-39, 2004.
10. Puvanendran K, Cheah JS, Naganathan N, Yeo PPB, Wong PK. Neuromuscular transmission in thyrotoxicosis. J Neurol Sci 43: 47-57, 1979.
11. Wortsman J, McConnachie P, Baker JR, Burman KD. Immunoglobulins that cause thyocyte proliferation from a patients with Graves' disease and an enlarged thymus. Am J Med 85: 117-121, 1988.
12. Murakami M, Hosoi Y, Negishi T, et al. Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus. J Clin Invest 98: 2228-2234, 1996.
13. Nicholle MW. Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease. Can J Neurol Sci 26: 201-203, 1999.
14. Jaretzki A, Steinglass KM, Sonett JR. Thymectomy in the management of Myasthenia gravis. Semin Neurol 24: 49-62, 2004.